Aaron I. Davis is of Mirati Therapeutics, Inc.. Currently has a direct ownership of 0 shares of MRTX, which is worth approximately $0. The most recent transaction as insider was on Jan 23, 2024, when has been sold 54,325 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0
0% 3M change
100.0% 12M change
Total Value Held $0

Aaron I. Davis Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jan 23 2024
SELL
Sale (or disposition) back to the issuer
-
54,325 Reduced 100.0%
0 Common Stock
Dec 29 2023
BUY
Grant, award, or other acquisition
$399,970 $58.75 p/Share
6,808 Added 11.14%
54,325 Common Stock
Jan 20 2023
BUY
Grant, award, or other acquisition
-
4,444 Added 8.55%
47,517 Common Stock
Jan 14 2022
BUY
Grant, award, or other acquisition
-
2,546 Added 5.58%
43,073 Common Stock
Jan 15 2021
BUY
Grant, award, or other acquisition
-
1,475 Added 3.51%
40,527 Common Stock

Also insider at

ODTC
Odonate Therapeutics, Inc. Financial Services
RAIN
Rain Therapeutics Inc. Healthcare
ITOS
iTeos Therapeutics, Inc. Healthcare
TNGX
Tango Therapeutics, Inc. Healthcare
AID

Aaron I. Davis

Newark, CA

Track Institutional and Insider Activities on MRTX

Follow Mirati Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells MRTX shares.

Notify only if

Insider Trading

Get notified when an Mirati Therapeutics, Inc. insider buys or sells MRTX shares.

Notify only if

News

Receive news related to Mirati Therapeutics, Inc.

Track Activities on MRTX